President, Chief Executive Officer and Secretary · Augmedix, Inc. (AUGX)

Emmanuel Krakaris

A named executive officer of Augmedix in every fiscal year CompBrief holds from FY2020 to FY2022. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,157,484

Salary $450,000Stock awards $0

FY2021: $1,755,675

1st of 3 named executive officers at Augmedix by FY2022 total.

3 named officers on file for Augmedix, FY2022

Emmanuel Krakaris’s pay file — $29

  • 3 fiscal years of pay, line by line

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Augmedix’s whole pay program stands against its peers

  • Augmedix’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on AUGX→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed June 26, 2023 (DEF 14A). Insider transactions since that proxy, current to 2026-11-21.

Free

Get Emmanuel Krakaris’s full pay file as a PDF — free

More than this page: up to 10 years of Emmanuel’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Emmanuel Krakaris compensation by year

Augmedix Summary Compensation Table · all 3 fiscal years held
In US dollars, as Augmedix reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2020FY2021FY2022
Salary$295,833$400,000$450,000
Bonus$0$0$0
Stock awards$0$0$0
Option awards$127,440$1,072,139$423,150
Non-equity incentive$210,000$280,000$280,000
Pension and deferred compensation$0$0$0
All other$900$3,536$4,334
Total$634,173$1,755,675$1,157,484

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Augmedix, Inc. DEF 14A filed June 26, 2023, accession 0001213900-23-051693, and prior-year filings.

How this page was built: the Augmedix, Inc. filed document, accession 0001213900-23-051693. Every figure is read from that document and cited to the page and table it appears in. Filed June 26, 2023.

$634K
$1.8M
$1.2M
FY20
FY21
FY22
SalaryNon-equity incentiveOption awardsAll other

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
Option337,819—$3.00
Option363,961—$3.00
Option46,273—$3.00
Option264,062—$2.48

Per the Outstanding Equity Awards at Fiscal Year-End table in Augmedix, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

16 Form 4 lines since the FY2022 proxy (filed June 26, 2023)
current to 2026-11-21 · updated nightly
DateTransactionPlanSharesPriceHeld after
2024-10-02Disposition to the issuer10b5-164,748$2.350
2024-10-02Disposition to the issuer derivative10b5-1800,820$0.000
2024-10-02Disposition to the issuer derivative10b5-1831,637$0.000
2024-10-02Disposition to the issuer derivative10b5-1131,250$0.000
2024-10-02Disposition to the issuer derivative10b5-1100,000$0.000
2024-10-02Disposition to the issuer derivative10b5-1325,000$0.000
2024-10-02Disposition to the issuer derivative10b5-1363,961$0.000
2024-10-02Disposition to the issuer derivative10b5-1505,036$0.000

The 8 most recent of 16 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

Augmedix’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Emmanuel Krakaris · this pagePresident, Chief Executive Officer and Secretary$1,157,484
Sandra BreberChief Operating Officer$736,396
Saurav ChatterjeeChief Technology Officer$633,352

Board service

Augmedix board · FY2022

How this board is paid

Company policy: Augmedix pays directors a $40,000 cash retainer and $100,000 in equity. As stated in Augmedix's FY2022 proxy.

The full Augmedix compensation record

free company brief

This page is one person within Augmedix's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Augmedix's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Emmanuel Krakaris's compensation dossier · One-time report. No refunds.